CAS 1338934-59-0

MKC8866

CAS : 1338934-59-0

MKC8866, a selective IRE1 RNase inhibitor with an IC50 of 0.29 μM, curbs breast and prostate cancer cell growth.

Formule : C₁₈H₁₉NO₇

Degré de pureté : 99.28% - 99.854%

Couleur et forme : Solid

Masse moléculaire : 361.35

Ref: TM-T15594

MKC8866

CAS : 1338934-59-0

Formule : C₁₈H₁₉NO₇

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 361.3460

Ref: IN-DA01EOOW

MKC8866

CAS : 1338934-59-0

MKC8866

Degré de pureté : ≥95%

Masse moléculaire : 361.35g/mol

Ref: 54-BUP12551

MKC8866

CAS : 1338934-59-0

MKC8866 is a selective antagonist that targets the metabotropic glutamate receptor 2 (mGluR2), which is a type of glutamate receptor expressed in various regions of the central nervous system (CNS). Derived from pharmacological research, this compound offers critical insights into the modulation of synaptic activity and neuronal signaling through inhibition of mGluR2.

Formule : C₁₈H₁₉NO₇

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 361.35 g/mol

Ref: 3D-NDC93459